BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$691M |
| 2 |
Microsoft
MSFT
|
+$544M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$455M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$429M |
| 5 |
Pfizer
PFE
|
+$421M |
Top Sells
| 1 |
Visa
V
|
+$818M |
| 2 |
Lam Research
LRCX
|
+$590M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
+$570M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$374M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
+$340M |
Sector Composition
| 1 | Technology | 26.44% |
| 2 | Financials | 10.71% |
| 3 | Consumer Discretionary | 10.59% |
| 4 | Healthcare | 9.73% |
| 5 | Communication Services | 7.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNSL
2651
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $78.3K | ﹤0.01% |
16,868
+1,252
| +8% | +$5.81K |
|
2652
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.28B
| $77.7K | ﹤0.01% |
4,306
+4,299
| +61,414% | +$77.6K |
|
2653
Tejon Ranch
TRC
$453M
| $77.5K | ﹤0.01% |
4,415
-473
| -10% | -$8.3K |
|
2654
First Business Financial Services
FBIZ
$437M
| $77.2K | ﹤0.01% |
1,693
+111
| +7% | +$5.06K |
|
2655
OR Royalties Inc.
OR
$6.75B
| $77K | ﹤0.01% |
4,159
-1
| -0% | -$19 |
|
2656
Aldeyra Therapeutics
ALDX
$334M
| $76.7K | ﹤0.01% |
14,229
+10,201
| +253% | +$55K |
|
2657
SIGA Technologies
SIGA
$649M
| $76.4K | ﹤0.01% |
11,322
-63,525
| -85% | -$429K |
|
|
DRD
2658
DRDGold
DRD
$1.97B
| $75.1K | ﹤0.01% |
7,787
-28,925
| -79% | -$279K |
|
2659
Utah Medical Products
UTMD
$200M
| $74.7K | ﹤0.01% |
1,117
+566
| +103% | +$37.9K |
|
2660
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.27B
| $74.6K | ﹤0.01% |
3,472
| – | – |
|
2661
Stoneridge
SRI
$232M
| $74.5K | ﹤0.01% |
6,662
-10,994
| -62% | -$123K |
|
2662
iShares MSCI Sweden ETF
EWD
$327M
| $74.2K | ﹤0.01% |
1,709
+20
| +1% | +$868 |
|
2663
StealthGas
GASS
$271M
| $74K | ﹤0.01% |
10,873
-15,490
| -59% | -$105K |
|
2664
Designer Brands
DBI
$224M
| $73.8K | ﹤0.01% |
9,996
-255,972
| -96% | -$1.89M |
|
2665
Oil-Dri
ODC
$970M
| $73.7K | ﹤0.01% |
2,136
-5,448
| -72% | -$188K |
|
2666
AB InBev
BUD
$115B
| $73.6K | ﹤0.01% |
1,111
-3,529
| -76% | -$234K |
|
2667
ArcelorMittal
MT
$26.7B
| $72.7K | ﹤0.01% |
2,768
-33,247
| -92% | -$873K |
|
2668
Microvision
MVIS
$346M
| $72.7K | ﹤0.01% |
63,752
-19,553
| -23% | -$22.3K |
|
2669
Lifeway Foods
LWAY
$499M
| $72K | ﹤0.01% |
2,778
+1,155
| +71% | +$29.9K |
|
2670
Schwab US Dividend Equity ETF
SCHD
$72.2B
| $71.7K | ﹤0.01% |
2,544
-1,356
| -35% | -$38.2K |
|
2671
Parke Bancorp
PKBK
$268M
| $71.6K | ﹤0.01% |
3,427
+1,235
| +56% | +$25.8K |
|
2672
Greif Class B
GEF.B
$2.48B
| $71.4K | ﹤0.01% |
1,023
+37
| +4% | +$2.58K |
|
2673
Southern First Bancshares
SFST
$371M
| $70.4K | ﹤0.01% |
2,066
+568
| +38% | +$19.4K |
|
2674
Anika Therapeutics
ANIK
$124M
| $70.2K | ﹤0.01% |
2,841
-149
| -5% | -$3.68K |
|
2675
DiaMedica Therapeutics
DMAC
$376M
| $69.1K | ﹤0.01% |
16,500
+1,300
| +9% | +$5.45K |
|